National Medicines Policy submission focuses on clinical practice Key recommendations for the policy’s review put forward by the RACGP are aimed at ensuring access, safety and quality.
Contraceptive pill to remain prescription only – at least for now The TGA is not due to make a final ruling until later this year, but GPs fear the implications if the interim decision is overturned.
Active Ingredient Prescribing grace period ends 31 July GPs and practices are being reminded to update their prescribing software to ensure legislative requirements are met.
New pharmacy trial seeks to break down barriers to contraception The trial, led by GP Professor Danielle Mazza, has been at the centre of debate following media misrepresentation.
How did the college advocate for members last month? The Federal Budget, pharmacy prescribing and new dedicated MBS item numbers for smoking cessation all elicited an RACGP response.
‘Unsafe and unnecessary’: RACGP opposes down-scheduling of the pill The college has said the ‘doubtful benefits’ of removing the need for a GP prescription do not outweigh the risks.
RACGP opposes pharmacy push for permanent continued dispensing The college has said a better and safer way to increase access to medicines under emergency situations would be to increase to the number of drugs included in the doctor’s bag.
GPs slam ‘worrying’, ‘opportunistic’ pharmacy COVID testing trial Queensland Health is pushing ahead with the planned trial despite concerns for the safety of pharmacists and the wider community.
GPs ‘horrified’ at latest pharmacy proposal The Pharmaceutical Society of Australia has suggested ‘non-urgent’ emergency department presentations be directed to community pharmacy.
Active Ingredient Prescribing to become mandatory from 1 February GPs have been reminded to update their clinical software in order to continue issuing legal prescriptions.